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Chronic traumatic encephalopathy (CTE) was initially 
described in boxers and colloquially known as ‘punch-drunk 
syndrome’. However, it has the potential to affect anyone 
exposed to repeated mild traumatic brain injury and hence 
represents a significant problem for players and governing 
bodies of contact sports worldwide. The morbidity of CTE 
can be significant, and is associated with a higher risk of 
dementia compared with the normal population. CTE has 
established pathological criteria from National Institute 
of Neurological Disorders and Stroke formulated in 2016, 
with irregular phosphorylated tau deposition in neurons and 
astroglia around blood vessels found at the base of cortical 
sulci necessary to confirm the diagnosis.
The syndrome of CTE, and its associated constellation of 
symptoms are now well described and have been identified 
in patients and former players engaged in a range of contact 
sports. The majority of early studies in this field focussed 
on establishing an understanding of pathophysiogy. How-
ever, current challenges for the field lie in quantifying CTE 
risk from individual contact sports, establishing whether 
tau is the only contributory pathway in the development of 
dementia in CTE, establishing novel therapeutic targets and 
developing a reliable ante-mortem biomarker for diagnosis 
and prognostication.
This article describes papers that expand our understand-
ing of CTE. The first quantifies risk of neurodegenerative 
disease and mortality in former players of association foot-
ball and compares this with the risk of death from other 
causes. The second study describes the contributions of 
white matter rarefaction and cerebrovascular pathology 
to dementia in CTE. Finally the third study describes the 
performance of a novel PET imaging ligand in predicting 
symptoms of CTE in traumatic brain injury and distinguish-
ing CTE patients from controls.
Neurodegenerative disease mortality 
among former professional soccer players
Association football (soccer) is the most popular sport in 
the world, and the growing recognition that playing soccer 
is associated with CTE has significant public health implica-
tions. However, the health benefits of playing sport are also 
recognised to reduce all cause mortality, particularly from 
cardiovascular causes. A public health policy limiting or 
restricting access to contact sports, which is not carefully 
considered, may therefore cause more harm than good. This 
retrospective case control study identified former profes-
sional footballers and compared mortality outcomes with a 
cohort of matched controls.
7,676 registered soccer players were recruited by search-
ing the records of the Scottish football museum and profes-
sional soccer clubs for registered professionals. The records 
(name and date of birth) were then linked with the com-
munity health number (a health record number unique to 
each individual in Scotland) on a probabilistic basis. For-
mer soccer players were matched to other individuals in the 
community health record by age, sex and deprivation index 
in a 1:3 ratio, resulting in a 23,028 strong control cohort. 
Outcomes were derived from death certificates (all-cause 
mortality; neurodegenerative disease; circulatory disease 
and respiratory disease). Prescribing data and deprivation 
indices were derived from national records. The analysis 
used cox-proportional hazard models, with a study endpoint 
of either mortality or December 2016.
Mortality in soccer players was lower until age 70, and 
increased thereafter (overall hazard ratio 0.87). Mortality 
from circulatory disease and respiratory disease was lower 
in soccer players compared with controls, but mortality from 
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neurodegenerative disease was higher and this disparity per-
sisted even when mortality for cardiovascular and respira-
tory cause was accounted for (hazard ratio 3.53). Players had 
a higher risk of dementia, motor neurone disease and Par-
kinson’s disease, and more frequent prescription of dementia 
related drugs than controls. In a subgroup analysis all-cause 
mortality and mortality secondary to neurodegenerative dis-
ease did not differ between outfield players and goalkeepers, 
but goalkeepers had fewer prescriptions for dementia related 
drugs than outfield players, consistent with known lower 
rates of traumatic brain injury (TBI) in goalkeepers.
Comment: Whilst this study is retrospective, the outcomes 
are based on death certificates and conclusions supported 
by prescribing records. The method for accounting for dep-
rivation has some limitations as it is based on last known 
address, potentially missing historical deprivation. Further-
more the algorithm for linking soccer club records to health 
records is not described in the paper in detail and all the 
participants were male, limiting generalisability. However, 
even with these caveats, the evidence that repeated low level 
concussions increase the risk of neurodegenerative disease 
and physical activity reduces the risk of cardio-respiratory 
disease are biologically plausible and supported by multiple 
outcomes.
Mackay DF et al. NEJM. 2019; 381(19): 1801–8.
Association of white matter rarefaction, 
arteriolosclerosis, and Tau with dementia 
in chronic traumatic encephalopathy
In Alzheimer’s disease, amyloid deposition, neurofibril-
lary tangles (NFT) and arteriosclerosis all contribute to the 
development of dementia. CTE is defined by phosphoryl-
ated tau deposition around arterioles, but the contribution 
of other pathological mechanisms to dementia is unknown. 
Without a clear understanding of the aetiology of demen-
tia in CTE, prospects for therapeutic intervention remain 
limited. This post-mortem study in a large cohort of former 
NFL (National Football League—American football) players 
assesses the contribution of tau and non-tau pathways to the 
development of dementia in CTE.
This study recruited former NFL players and included all 
cases meeting pathological criteria for CTE. Neuropatholo-
gists assessed the samples blinded to clinical data. Neurofi-
brillary tangles and tau were measured in the dorso-lateral 
prefrontal cortex (the area with the highest burden of tau 
deposition in CTE). Four regions (inferior parietal, middle 
frontal, superior temporal and occipital) were sampled for 
white matter rarefaction (WMR: myelin loss, vacuolisation 
around small blood vessels and reactive astrocyte density) 
and arteriosclerosis (hyaline thickening of arterioles). Micro 
bleeds and infarctions were measured throughout the whole 
brain. Information on symptoms of dementia was made 
retrospectively by telephone with an interview with a car-
egiver; dementia diagnosis was according to DSM V criteria. 
Simultaneous regression modelling assessed contributions 
to dementia diagnosis.
224 men were recruited; 14 were excluded for incom-
plete data and 30 were excluded as they died before age 40. 
120/180 in the final sample had dementia. Increasing age 
was associated with higher levels of dementia, WMR and 
CTE grade (tau deposition). Increasing years of play (a sur-
rogate for number of repetitive TBIs) was associated with 
increased WMR, higher NFT burden and worse CTE grade. 
WMR and NFT were equally associated with dementia. 
Arteriosclerosis was associated with dementia and vascu-
lar risk factors, but not years of play. A sensitivity analysis 
showed that WMR in this cohort was not associated with 
vascular risk factors or arteriosclerosis.
Comment: This study shows that TBI induced axonal 
damage is a major contributor to dementia in CTE in addi-
tion to tau deposition. Although the case ascertainment 
raises the possibility of selection bias (as the sample was 
composed of volunteers and entirely male) and the diagno-
sis of dementia was retrospective and not based on clinical 
assessment, the findings remain significant. Importantly, 
the white matter damage in CTE is independent of vascular 
disease.
Alosco ML et al. JAMA Neurol. 2019;76(11):1298–1308.
PET‑detectable tau pathology correlates 
with long‑term neuropsychiatric outcomes 
in patients with traumatic brain injury
Currently a diagnosis of CTE can only formally be made 
post-mortem. The lack of a reliable ante-mortem diagnosis 
and inability to track disease progression are major limita-
tions in aetiological and therapeutics studies in CTE. This 
study measured the ability of a novel tau-specific PET ligand 
to distinguish CTE participants from controls and measure 
symptoms in the CTE cohort.
The authors recruited participants with severe or chronic 
repetitive TBI aged over 20 who were free of neurological 
or psychiatric symptoms prior to TBI, and a cohort of com-
munity controls. All participants completed a questionnaire 
relating to symptoms of CTE (Traumatic encephalopathy 
syndrome, TES), assessments of cognition (a battery of tasks 
including MMSE, in addition to tasks focussing on memory, 
attention and executive function) and psychiatric symptoms 
(questionnaire measures of apathy, psychosis and depres-
sion). All participants underwent quantitative PET with a 
novel ligand (11C-PBB3) shown to reliably detect tau deposi-
tion post-mortem in a previous study.
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27 participants with TBI (14 with symptoms of CTE) 
and 15 controls were recruited. The TBI group had higher 
quantitative binding in the neocortex, particularly in the tem-
poral and occipital regions compared with controls. Higher 
11C-PBB3 binding was also found in the white matter of 
the TBI group (frontal, occipital and temporal) compared to 
controls. The symptomatic TBI group had higher 11C-PBB3 
binding in the medial frontal white matter compared with 
the asymptomatic TBI group; grey matter ligand binding 
did not differ between groups. Medial frontal white matter 
11C-PBB3 correlated with psychosis scores and localised to 
superficial white matter.
Comment: This PET ligand has been previously shown 
to reliably localise tau in post-mortem samples; this study 
shows that quantitative 11C-PBB3 PET binding is higher in 
TBI cases compared with controls, and also in symptomatic 
compared with asymptomatic patients. Whilst the authors 
did not correct for multiple comparisons when assessing the 
correlations between PET and cognitive tasks or psychiatric 
symptoms, the potential for use as a biomarker is significant. 
The biological plausibility is strengthened by the pattern 
of PET binding—showing a frontal and superficial white 
matter pattern.
Takahata K et al. Brain. 2019; 142: 3265–3279.
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